Showing results (61-70 of 71) with videos related to
Sort By:
Pageof 8
Frontiers in Pharmacology|October 28, 2022
<i>In vitro</i> neutrophil migration is associated with inhaled corticosteroid treatment and serum cytokines in pediatric asthmaSolveig Lemmel, Markus Weckmann, Anna Wohlers, et al.Ebiomedicine|July 11, 2025
Genotype and transcript processing of the tumour necrosis factor receptor TNFRSF1A in epithelial cells: implications for survival in cystic fibrosisAlexander Uden, Inga Dunsche, Sabina Janciauskiene, et al.American Journal of Respiratory and Critical Care Medicine|May 10, 2022
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two <i>F508del</i> AllelesSimon Y Graeber, Diane M Renz, Mirjam Stahl, et al.The European Respiratory Journal|June 20, 2024
Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two <i>F508del</i> allelesMirjam Stahl, Martha Dohna, Simon Y Graeber, et al.ERJ Open Research|December 2, 2020
Multicentre feasibility of multiple-breath washout in preschool children with cystic fibrosis and other lung diseasesMirjam Stahl, Cornelia Joachim, Ines Kirsch, et al.American Journal of Respiratory and Critical Care Medicine|December 8, 2023
17q21 Variants Disturb Mucosal Host Defense in Childhood AsthmaConstanze A Jakwerth, Markus Weckmann, Sabina Illi, et al.The European Respiratory Journal|July 30, 2021
COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapyMarkus Weckmann, Thomas Bahmer, Jannie Marie Sand, et al.The European Respiratory Journal|September 18, 2025
Reduction of systemic inflammation by elexacaftor/tezacaftor/ivacaftor correlates with lung function improvement in cystic fibrosisOlga Halle, Simon Y Graeber, Julia Kontsendorn, et al.Allergy|October 16, 2025
Immune Training of the Interleukin 6 Gene in Airway Epithelial Cells is Central to Asthma ExacerbationsLars P Lunding, Markus Weckmann, Ulrich M Zissler, et al.The European Respiratory Journal|February 25, 2022
T2-high asthma phenotypes across lifespanNicole Maison, Jimmy Omony, Sabina Illi, et al.Pageof 8